genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
    • Lung Cancer
      Cancer

      Changing Carcinogenic Cells in the Lungs with Novel Technology

      Human microbiome
      Gastrointestinal Disorders

      GI GVHD Link to Microbiome Dysbiosis Addressed by Reducing Intestinal Oxygen

      Cancer

      Molecular Anchor Creates More Effective CAR T Immunotherapies

      White House
      Cancer

      White House Continues Dedication to “End Cancer as We Know It”

      Cancer Cells
      Cancer

      Molecular Pathways Used by Metastatic Cancer Cells Uncovered

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      ames Watson and Francis Crick
      OMICs

      Reflections on the Double Helix’s Platinum Anniversary

      Evozyne’s office in Chicago, IL
      Artificial Intelligence

      AI and Computational Design Advance Protein Engineering

      Woman Checking label in lab
      Bioprocessing

      In Pursuit of Rare, Subtle, and Fleeting Post-Translational Modifications

      Clear Labs male worker
      Infectious Diseases

      Tripledemic Rouses Vaccine Developers and Variant Trackers

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      stocks go up
      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Home Companies shire

shire

  • 23andMe
  • Abbvie
  • AdnaGen
  • Agilent Technologies
  • Alexion Pharmaceuticals
  • Amgen
  • Astellas
  • AstraZeneca
  • Audentes Therapeutics
  • Berkeley Lights
  • Bio-Rad Laboratories
  • Biogen
  • Cancer Genetics
  • Catalent
  • Charles RIver Laboratories
  • Dana-Farber Cancer Institute
  • deCODE genetics
  • Dicerna
  • Dimension Therapeutics
  • Exact Sciences
  • Foundation Medicine
  • GE Healthcare
  • GeneInsight
  • Gilead Sciences
  • GlaxoSmithKline
  • Halozyme Therapeutics
  • Hitachi High-Technologies
  • Horizon Discovery Group
  • Human Longevity
  • Illumina
  • Jackson Laboratory
  • Janssen Biotech
  • LabCorp
  • Maravai LifeSciences
  • MD Anderson
  • MDxHealth
  • MedImmune
  • Memorial Sloan Kettering Cancer Center
  • Merck & Co
  • Merck KGaA
  • NanoString Technologies
  • Novartis
  • Pathology
  • PerkinElmer
  • PersonalizeDx
  • Qiagen
  • RayBiotech
  • Roche
  • Sanofi
  • shire
  • Sigma-Aldrich
  • Synthego
  • Takeda
  • Thermo Fisher Scientific
  • UCB Biosciences
    Latest
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Business meeting
    shire

    Shire, Takeda Shareholders Approve $58.5B Acquisition Deal

    shire

    Shire Licenses Rare Liver Disease Candidates to $120M Startup Mirum

    Sanofi’s global vaccines unit Sanofi Pasteur has launched an up-to-$805 million partnership with Translate Bio to develop messenger RNA vaccines for up to five undisclosed infectious disease pathogens. [Ryan Jeffs/Wikicommons]
    shire

    Sanofi Pasteur, Translate Bio Launch mRNA Vaccine Partnership

    shire

    Shire, Takeda Come to Terms on $62B Acquisition Deal

    shire

    Shire Board Sets Stage for $64B Takeda Acquisition, If Companies Resolve Details

    shire

    Shire Rejects Takeda Takeover Bids

    shire

    Servier to Acquire Shire’s Oncology Business for $2.4B

    shire

    Shire Pursues FDA Approval for Plasma Manufacturing Facility

    shire

    Lonza Expands in Mammalian Manufacturing with Purchase of California Site

    shire

    Shire Transfers IND for GvHD Candidate to Kamada

    shire

    Shire Hemophilia Candidate Using Xenetic Platform Falls Short in Trial

    shire

    Shire Plans Lanadelumab BLA Submission Following Positive Phase III HAE Results

    shire

    Shire, Parion Ink Deal for Up to $535M to Develop Phase...

    shire

    EC Approves Shire’s Recombinant Parathyroid Hormone for Hypoparathyroidism

    shire

    RaNA Therapeutics Acquires Shire’s mRNA Platform

    Recently Featured

    Changing Carcinogenic Cells in the Lungs with Novel Technology

    Changing Carcinogenic Cells in the Lungs with Novel Technology

    GI GVHD Link to Microbiome Dysbiosis Addressed by Reducing Intestinal Oxygen

    GI GVHD Link to Microbiome Dysbiosis Addressed by Reducing Intestinal Oxygen

    White House Continues Dedication to “End Cancer as We Know It”

    White House Continues Dedication to “End Cancer as We Know It”

    Molecular Pathways Used by Metastatic Cancer Cells Uncovered

    Molecular Pathways Used by Metastatic Cancer Cells Uncovered

    Read the Digital Edition

    GEN February 2023 cover

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up